The Damage of Ocular Surface Due to Uncontrolled Intraocular Pressure in Neovascular Glaucoma

1. Melamed S, Ben-Sira, Ben-Shaul. Corneal endothealial changes under induced intraocular pressure elevation: a scanning and transmission electron microscopic study in rabbits. British Journal of Ophthalmology. 1980;64:164-169.10.1136/bjo.64.3.16410393807387948Search in Google Scholar

2. Li X, Zhang Z, Ye L, Meng J, Zhao Z, Liu Z, Hu Z. Acute ocular hypertension disrupts barrier integrity and pump function in rat corneal endothelial cells. Scientific Reports, Nature; 2017.10.1038/s41598-017-07534-9553740528761172Search in Google Scholar

3. Olmos LC, Lee RK. Medical and Surgical Treatment of Neovascular Glaucoma. Bascom Palmer Eye Institute, University of Miami Miller School of Medicine Miami, FL, Int Ophthalmol Clin. 2011;51(3):27–36.Search in Google Scholar

4. Borgman CJ. Neovascular Glaucoma: A Serious Secondary Condition. Review of Optometry; 2014.Search in Google Scholar

5. Satoko Nakano, Takako Nakamuro, Katsuhiko Yokoyama, Kunihiro Kiyosaki, Toshiaki Kubota, Prognostic Factor Analysis of Intraocular Pressure with Neovascular Glaucoma. Journal of Of Ophtalmology. 2016 Volume 2016 |Article ID 1205895 https://doi.org/10.1155/2016/120589510.1155/2016/1205895499251827579175Search in Google Scholar

6. Rodrigues AI, Sheng L. Reversing the rubeotic rampage – Current approaches in the management of neovascular glaucoma, European Ophthalmic Review. 2016;10(1):19–21.10.17925/EOR.2016.10.01.19Search in Google Scholar

7. Nakano S, Nakamuro T, Yokoyama K, Kiyosaki K, Kubota T. Prognostic Factor Analysis of Intraocular Pressure with Neovascular Glaucoma. J Ophtalmol; 2016.10.1155/2016/1205895Search in Google Scholar

8. Park J, Lee M. Short-term effects and safety of an acute increase of intraocular pressure after intravitreal bevacizumab injection on corneal endothelial cells, BMC Ophthalmology. 2018;18:17.10.1186/s12886-018-0682-9Search in Google Scholar

9. Sun Y, Liang Y, Zhou P, Wu H, Hou X, Ren Z, Li X, Zhao M. Anti- VEGF treatment is the key strategy for neovascular glaucoma management in the short term. BMC Ophthalmology. 2016;16:150.https://www.google.com/search?tbo=p&tbm=pts&hl=en&q=ininventor:%22Mark+Cedric+Gillies%2210.1186/s12886-016-0327-9500632127576739Search in Google Scholar

10. Gillies MC, Morlet N, Sarossy MG. Treating ophthalmic fibrosis using interferon-.alpha”, Sydney, Australia, Jan.; 1999.Search in Google Scholar

11. Gillies M, Su T, Sarossy M, Hollows F. Interferon-alpha 2b inhibits proliferation of human Tenon’s capsule fibroblasts”, Department of Ophthalmology P rince of Wales Hospital Ranwick, Auastralia; 199310.1007/BF009202258444359Search in Google Scholar

12. Gillies MC, Goldberg I, Stephanie H, Su, Tao. Glaucoma filtering surgery with interferon alpha-2b, Journal of Glaucoma. 1993;2(24).10.1097/00061198-199300240-00001Search in Google Scholar